Use of biomarkers in assessing health and environmental impacts of chemical pollutants
Author(s)
Bibliographic Information
Use of biomarkers in assessing health and environmental impacts of chemical pollutants
(NATO ASI series, Ser. A . Life sciences ; v. 250)
Plenum Press, c1993
Available at 11 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
"Proceedings of a NATO Advanced Research Workshop on Use of Biomarkers in Assessing Health and Environmental Impacts of Chemical Pollutants, held June 1-5, 1992, in Luso, Portugal"--T.p. verso
"Published in cooperation with NATO Scientific Affairs Division."
Includes bibliographical references and index
Description and Table of Contents
Description
Biological markers (biomarkers) are useful tools for understanding the nature and extent of human exposure and risk from environmental toxicants. Biomarkers are classified into three basic categories: exposure, effect, or susceptibility. A marker of exposure is the product of the interaction between a target cell or molecule and a foreign substance (NAS, 1989). These markers can be used to determine the biologically effective dose necessary to elicit a particular physiological change in an organism. A marker of effect is a biochemical or physiological change in an organism that can predict the onset of adverse health effects resulting from a given exposure. Lastly, markers of susceptibility act as indicators of an inherent or acquired tendency of an organism to experience an adverse health effect (NAS, 1989). These markers are already used to detect a variety of diseases and show great promise for developing a better understanding of the mechanicisms of disease. Additionally, biomarkers can be used to establish a more rational basis for quantitative risk extrapolation between species, as weIl as to obtain more precise estimates of the time of critical exposure. These markers can also prove helpful in identifying potentially damaging exposures before the onset of adverse health effects. Biomarkers serve as a valuable exposure assessment tool because they take into account exposure from all routes and integrate exposure from all sources. They have the potential to yield better risk estimates than current monitoring and modeling protocols. In lune 1992, Dr. Travis and Dr.
Table of Contents
- Molecular Dosimetry: Use of Biomarkers in Quantitative Risk Assessment
- L. Rhomberg. Dose Response Relationships for Mutagenic and Carcinogenic Action of Genotoxic Agents: Measurement of Mutation Spectra as a Molecular Dosimeter
- W.G. Thilly. Biomarkers of Environmental Exposure: Public Health Assessment as a Tool in Identifying Human Exposure to Environmental Pollutants
- M.M. Bashor. Biomarkers of Toxicity: Stress Proteins as Biomarkers of Toxicity
- P.L. Goering, et al. Biological Markers in Reproductive Toxicology
- Outcome Based Biomarkers of Female Reproduction
- J.F. Jarrell. Biomarkers of Neurotoxicity: Behavioral Biomarkers to Identify Neurotoxic Effects
- W.K. Anger. Ecological Biomarkers: Animals and Plants as Bioindicators of Radionuclide Contamination in Forest Ecosystems
- R.T. Palo. Tumor Markers: Tumor Markers in Effusions
- I. Gullu, et al. 19 additional articles. Index.
by "Nielsen BookData"